Antimicrobial stewardship and resistance in intensive care units in the UK : a prospective national audit
Summary Introduction Principles of effective antimicrobial stewardship include prescription of empiric therapy based on the most likely causative organism, with medication review within 72 h. Adherence to best practice in UK ICUs is unknown and the aim of this study was to evaluate patient‐ and unit‐level antimicrobial use in UK ICUs. Methods We conducted a prospective national audit of antimicrobial use in adults (aged ≥ 18 y) admitted to ICUs in the UK and Isle of Man with a point‐prevalence survey. Subsequently, we collected longitudinal data on review of therapy and antimicrobial resistance in a subset of patients who had commenced therapy within the previous 3 days. Results We studied 2626 patients from 154/292 (52.7%) ICUs. Antimicrobial therapy was prescribed in 1592 (60.6%) patients. Of 2116 empiric antimicrobial orders, 1592 (75.2%) were compliant with unit‐level guidelines. For non‐compliant orders, 253 (12.0% of all empiric orders) were discussed with infection specialists and 69 (3.3%) provided justification for off‐guidance therapy, but 202 (9.5%) were prescribed outside guidance without justification or discussion with infection specialists. Guideline‐compliant review within 72 h of prescription took place in 1488/1606 (92.7%) eligible medication orders. A pre‐specified stop or review date was strongly associated with antimicrobial review within 72 h (adjusted OR 9.3, 95%CI 5.4–16.2). Discussion We have benchmarked critical care antimicrobial stewardship and guideline compliance across the UK. We recommend that pre‐specified review dates are added to all prescriptions, as the most important determinant of review identified in our audit. Future work should include national stewardship audit cycles to benchmark practice and inform quality improvement initiatives.
Authors
- David Oliver Hamilton (ORCID: https://orcid.org/0000-0001-9475-5030)
- Joseph M. Lewis (ORCID: https://orcid.org/0000-0002-3837-5188)
- Adam Paul Roberts (ORCID: https://orcid.org/0000-0002-0760-3088)
- Alicia Waite (ORCID: https://orcid.org/0000-0001-8734-994X)
- Neil Botting
- Daniel Wagstaff (ORCID: https://orcid.org/0009-0004-8351-6404)
- A. H. C. Morris (ORCID: https://orcid.org/0000-0002-5478-933X)
- Diane A.I. Ashiru-Oredope (ORCID: https://orcid.org/0000-0001-9579-2028)
- Adam Jonathan Boulton (ORCID: https://orcid.org/0000-0002-2115-1129)
- Luke Flower (ORCID: https://orcid.org/0000-0001-7204-609X)
- Rachel Berry (ORCID: https://orcid.org/0009-0009-9922-1156)
- Jasmin Islam (ORCID: https://orcid.org/0000-0002-4369-6306)
- Reena Mehta
- Ben Morton (ORCID: https://orcid.org/0000-0002-6164-2854)
- Andrew James Boyle (ORCID: https://orcid.org/0000-0002-6201-805X)
- Paul Dean (ORCID: https://orcid.org/0000-0002-2822-4677)
- for the TRIC‐MAN study team
- Devan Williams
Institutions
- Queen's University Belfast (GB)
- University of Liverpool (GB)
- King's College London (GB)
- Liverpool School of Tropical Medicine (GB)
- University of Cambridge (GB)
- Liverpool University Hospitals NHS Foundation Trust (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- University Hospitals Coventry and Warwickshire NHS Trust (GB)
- University Hospital Southampton NHS Foundation Trust (GB)
- University of Warwick (GB)
- Intensive Care Society (GB)
- King's College Hospital NHS Foundation Trust (GB)
- Royal Victoria Hospital (GB)
- University Hospitals Sussex NHS Foundation Trust (GB)
- Addenbrooke's Hospital (GB)
Publication Details
- Journal
- Anaesthesia
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1111/anae.70460
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 0.00